🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Non Invasive Neurostimulation Technology for the Treatment of Type I Complex Regional Pain Syndrome (CRPS I)

RecruitingNAAges 18 Years - anyAllUniversity of Las Palmas de Gran Canaria
NCT05052736 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Complex Regional Pain Syndrome (CRPS) / Complex Regional Pain Syndrome (CRPS) is a chronic neurological disorder that affects the extremities and is characterized by disabling pain, swelling, vasomotor instability, sudomotor abnormality, and impaired motor function; the duration and clinical magnitude is greater than expected, being divided into three stages of progression over time: Stage I: acute (0-3 months); Stage II: dystrophic (3-9 months); Stage 3: atrophic (9-18 months). The purpose of this study is to investigate the effect on complex pain syndrome using a conventional care protocol plus the application of non-invasive neuromodulation during compared to the effect of the same protocol plus placebo.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Meet the Budapest criteria for the clinical diagnosis of CRPS type I. * Age between 18 and 65. * Period between 0 and 6 months after the onset of the clinical picture. * Have signed the informed consent of their own free will. Exclusion Criteria: * Have a diagnosis of CRPS type II. * Present type I CRPS in more than one limb. * Patients who have suffered a recurrence of CRPS type I. * Pregnancy or plans for it during the study. * Previous sympathectomy in the affected limb.
💊

What it tests

  • Non-invasive Neuromodulation
📍

Where

1 site
Aníbal Báez Suárez
Las Palmas de Gran Canaria, Spain
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy